a developer of autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions
Industry Biotechnology
A.I.dvisor indicates that over the last year, ENLV has been loosely correlated with APVO. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ENLV jumps, then APVO could also see price increases.
Ticker / NAME | Correlation To ENLV | 1D Price Change % | ||
---|---|---|---|---|
ENLV | 100% | +10.50% | ||
APVO - ENLV | 37% Loosely correlated | +15.33% | ||
ONCT - ENLV | 34% Loosely correlated | -1.72% | ||
FATE - ENLV | 32% Poorly correlated | +10.63% | ||
VKTX - ENLV | 30% Poorly correlated | +1.86% | ||
SLNO - ENLV | 29% Poorly correlated | +5.77% | ||
More |